Abbvie Inc (ABBV)
213.59 -3.07 (-1.42%) 03/11/25 [NYSE]
212.01 x 100 215.96 x 100
Realtime by (Cboe BZX)
212.01 x 100 215.96 x 100
Realtime - - (-) -
for Tue, Mar 11th, 2025
Results
download Want to compare other data? Select Fields| Symbol | ABBV | JNJ | NVO | ||
| Company | Abbvie Inc | Johnson & Johnson | Novo Nordisk A/S ADR | ||
| Price Information | |||||
| Exchange | NYSE | NYSE | NYSE | ||
| Open | 216.66 | 167.20 | 78.88 | ||
| High | 216.66 | 167.30 | 79.27 | ||
| Low | 212.41 | 165.05 | 77.00 | ||
| Last | 213.59 | 165.86 | 78.11 | ||
| Change | -3.07 | -1.84 | -0.84 | ||
| % Change | -1.42% | -1.10% | -1.06% | ||
| Volume | 7,144,500 | 9,890,600 | 7,433,400 | ||
| 20-Day Average Volume | 6,168,725 | 9,959,936 | 7,900,035 | ||
| Previous Close | 216.66 | 167.70 | 78.95 | ||
| Industry | Large Cap Pharma | Large Cap Pharma | Large Cap Pharma | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 203.95 | 162.26 | 85.54 | ||
| 20-Day Raw Stochastic | 83.32% | 75.34% | 6.61% | ||
| 20-Day Relative Strength | 69.66% | 63.21% | 38.74% | ||
| Weighted Alpha | +26.40 | +8.57 | -46.26 | ||
| Today's Opinion | 100% Buy | 40% Buy | 88% Sell | ||
| Previous Opinion | 100% Buy | 40% Buy | 80% Sell | ||
| Last Month's Opinion | 24% Buy | 24% Sell | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.81% since 03/04/25 | +0.27% since 03/04/25 | -10.73% since 03/04/25 | ||
| Low | 206.00 on 03/05/25 | 163.51 on 03/06/25 | 77.00 on 03/11/25 | ||
| High | 218.66 on 03/10/25 | 169.90 on 03/10/25 | 91.90 on 03/05/25 | ||
| 1-Month | |||||
| %Chg | +11.34% since 02/11/25 | +6.23% since 02/11/25 | -6.72% since 02/11/25 | ||
| Low | 190.39 on 02/12/25 | 153.24 on 02/18/25 | 77.00 on 03/11/25 | ||
| High | 218.66 on 03/10/25 | 169.99 on 03/04/25 | 93.80 on 02/25/25 | ||
| 3-Month | |||||
| %Chg | +22.49% since 12/11/24 | +13.11% since 12/11/24 | -30.07% since 12/11/24 | ||
| Low | 168.06 on 01/22/25 | 140.68 on 01/10/25 | 77.00 on 03/11/25 | ||
| High | 218.66 on 03/10/25 | 169.99 on 03/04/25 | 111.17 on 12/12/24 | ||
| 6-Month | |||||
| %Chg | +9.76% since 09/11/24 | +0.63% since 09/11/24 | -42.24% since 09/11/24 | ||
| Low | 163.81 on 11/19/24 | 140.68 on 01/10/25 | 77.00 on 03/11/25 | ||
| High | 218.66 on 03/10/25 | 169.99 on 03/04/25 | 138.22 on 09/16/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 377,062,144 | 399,327,360 | 350,521,152 | ||
| Shares Outstanding, K | 1,765,355 | 2,407,617 | 4,487,532 | ||
| Annual Sales | 56,334,000,000 | 88,821,000,000 | 42,108,430,000 | ||
| Annual Net Income | 4,278,000,000 | 14,066,000,000 | 14,643,260,000 | ||
| Last Quarter Sales | 15,102,000,000 | 22,520,000,000 | 12,261,320,000 | ||
| Last Quarter Net Income | -22,000,000 | 3,431,000,000 | 4,026,620,000 | ||
| 60-Month Beta | 0.61 | 0.47 | 0.42 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 2.16 on 01/31/25 | 2.04 on 01/22/25 | 0.91 on 02/05/25 | ||
| Latest Earnings Date | 04/25/25 | 04/15/25 | 05/01/25 | ||
| Most Recent Dividend | 1.640 on 01/15/25 | 1.240 on 02/18/25 | 0.362 on 08/16/24 | ||
| Next Ex-Dividends Date | 04/15/25 | 02/18/25 | 03/31/25 | ||
| Ratios | |||||
| Price/Earnings ttm | 21.41 | 16.79 | 24.00 | ||